跳至主要内容
临床试验/EUCTR2004-002824-16-SE
EUCTR2004-002824-16-SE进行中(未招募)不适用

Spinalt klonidin och baklofen som adjuvans till ryggmärgsstimulering vid terapiresistent smärta. (Möjlighet att förstärka den smärtlindrande effekten av alektrisk tyggmärgsstimulering med läkemedel som tillförs via ryggmärgskanalen)

Karolinska Universitetssjukhuset0 个研究点开始时间: 2004年11月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Patients with neuropathic pain who have received a temporary electrode system for spinal cord stimulation, but experience pain reduction less than 50% or pain reduction not exeeding 45 minutes after completed spinal cord stimulation session.
  • 2) Patients who previously have received a fully implanted system for spinal cord stimulation as a treatment for neuropathic pain, where pain-relief has diminished so that they now experience pain reduction less than 50% or pain reduction not exeeding 45 minutes after completed spinal cord stimulation session.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) Mental handicap or other disturbance of communication.
  • 2) Ongoing infection.
  • 3) CNS disease
  • 4) Heart- or other vascular disease.
  • 5) Medication that may interact with the test substances.

研究者

相似试验